Seed Train Optimization in Microcarrier-Based Cell Culture Post In Situ Cell Detachment through Scale-Down Hybrid Modeling
-
Published:2024-03-09
Issue:3
Volume:11
Page:268
-
ISSN:2306-5354
-
Container-title:Bioengineering
-
language:en
-
Short-container-title:Bioengineering
Author:
Ebrahimian Atefeh123ORCID, Schalk Mona12, Dürkop Mark4ORCID, Maurer Michael2ORCID, Bliem Rudolf23, Kühnel Harald2ORCID
Affiliation:
1. ACIB—Austrian Centre of Industrial Biotechnology, Krenngasse 37, 8010 Graz, Austria 2. Department of Applied Life Science, Bioengineering, FH-Campus Wien, 1100 Vienna, Austria 3. Department of Biotechnology, University of Natural Resources and Life Sciences, 1190 Vienna, Austria 4. Novasign GmbH, 1020 Vienna, Austria
Abstract
Microcarrier-based cell culture is a commonly used method to facilitate the growth of anchorage-dependent cells like MA 104 for antigen manufacturing. However, conventionally, static cell culture is employed for cell propagation before seeding the production bioreactor with microcarriers (MCs). This study demonstrates the effective replacement of the conventional method by serial subculturing on MCs with in situ cell detachment under optimal conditions in closed culture units. This study proves that MA 104 can be subcultured at least five times on Cytodex 1 MC without the need for separating cells and MC after cell harvest. Process parameters impacting cell growth were studied post in situ cell detachment in a scaled-down model. Optimization, using augmented Design of Experiments (DoE) combined with hybrid modeling, facilitated rapid screening of the design space for critical process parameters (CPPs). Optimized conditions included an inoculation density of >16 cells/bead, 3.5–4.5 g/L of Cytodex 1, and a controlled agitation speed, starting at Njs (minimum agitation speed) for the first day with a maximum increase of 25% thereafter. With these design spaces for CPPs, a cell density of 2.6 ± 0.5 × 106 cells/mL was achieved after five days. This refined bioprocess methodology offers a reliable and efficient approach for seed training in stirred tank reactors, which is particularly beneficial for viral vaccine production.
Funder
Austrian Research Promotion Agency BMK, BMDW, SFG, Standortagentur Tirol, Government of Lower Austria und Vienna Business Agency
Reference58 articles.
1. Ellebedy, A.H., and Ahmed, R. (2016). The Vaccine Book, Elsevier. 2. Hajiaghapour Asr, M., Dayani, F., Saedi Segherloo, F., Kamedi, A., Neill, A.O., MacLoughlin, R., and Doroudian, M. (2023). Lipid Nanoparticles as Promising Carriers for mRNA Vaccines for Viral Lung Infections. Pharmaceutics, 15. 3. Liu, T., Liang, Y., and Huang, L. (2021). Development and Delivery Systems of mRNA Vaccines. Front. Bioeng. Biotechnol., 9. 4. Suspended cell lines for inactivated virus vaccine production;Zhang;Expert Rev. Vaccines,2023 5. Zhuang, L., Ye, Z., Li, L., Yang, L., and Gong, W. (2023). Next-Generation TB Vaccines: Progress, Challenges, and Prospects. Vaccines, 11.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|